Global Endotherapy Devices Market Size By Type (GI Devices And Accessories, ERCP Devices And Accessories), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Endotherapy Devices Market was valued at USD 4.6 billion in 2023 and is anticipated to reach USD 8.9 billion by 2031, growing at a CAGR of 8.4% during the forecast period from 2023 to 2031. This growth is attributed to the increasing prevalence of gastrointestinal diseases, rising preference for minimally invasive procedures, and continuous technological advancements in endoscopic therapies. With a significant increase in geriatric population and healthcare infrastructure improvements worldwide, the demand for effective and minimally traumatic treatments like endotherapy is accelerating.

Drivers

1. Rising Incidence of GI Disorders and Cancer:

The growing burden of gastrointestinal disorders, such as colorectal cancer, peptic ulcers, and Barrett’s esophagus, is a significant driver. Early diagnosis and treatment via endotherapy are crucial, boosting the adoption of these devices in hospitals and ambulatory surgical centers.

2. Technological Advancements in Endoscopic Procedures:

Ongoing innovations, including high-definition imaging, robotic assistance, and improved device ergonomics, are enhancing procedural outcomes, safety, and patient recovery times, further fueling market growth.

3. Surge in Minimally Invasive Surgeries:

Patients increasingly prefer less invasive interventions due to benefits like reduced hospital stays, minimal scarring, and faster recovery, leading to higher demand for endotherapy devices.

Restraints

1. High Equipment and Maintenance Costs:

The initial investment and ongoing maintenance expenses for endotherapy systems can be prohibitively high, particularly in underfunded healthcare systems and smaller clinics.

2. Regulatory and Reimbursement Challenges:

Stringent approval processes and varied reimbursement scenarios across regions can hinder market expansion, especially in developing economies.

Opportunity

1. Expanding Healthcare Access in Emerging Markets:

Rapid healthcare infrastructure development in Asia-Pacific and Latin America provides lucrative opportunities for manufacturers, driven by increasing patient awareness and government initiatives.

2. Development of AI and Image-Guided Endotherapy:

Integrating artificial intelligence and image-guidance in endotherapy holds immense potential for precision diagnostics and treatment personalization.

Market by System Type Insights

Based on system type, the GI Stents segment held the dominant market share in 2023. These stents are widely used in managing obstructions and strictures in the gastrointestinal tract. However, the Biopsy Forceps segment is expected to witness the fastest growth due to the increasing demand for accurate tissue sampling in diagnostics.

Market by End-use Insights

By end-use, the Hospitals segment accounted for the largest revenue share in 2023, owing to the availability of advanced endoscopy suites and trained professionals. The Ambulatory Surgical Centers (ASCs) segment is projected to register the highest CAGR during the forecast period, driven by the shift toward outpatient and cost-effective treatment settings.

Market by Regional Insights

North America led the market in 2023, driven by a robust healthcare infrastructure, early adoption of technology, and high disease prevalence. However, Asia-Pacific is forecasted to be the fastest-growing region due to increasing healthcare expenditure, a large patient pool, and supportive government policies.

Competitive Scenario

Key players in the Global Endotherapy Devices Market include Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Medtronic plc, Cook Medical, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Steris PLC, Pentax Medical, and Smith & Nephew plc. These companies are focused on innovation, strategic mergers, and regional expansions to strengthen their market positions.

Scope of Work – Global Endotherapy Devices Market

Report Metric Details

Market Size (2023) USD 4.6 Billion

Projected Market Size (2031) USD 8.9 Billion

CAGR (2023-2031)